Skip to main content

Exapto

Exapto provides biomanufacturing solutions that increase the performance and competitiveness of existing bioproductions while enabling access to chemicals previously unreachable from renewable resources. The company integrates synthetic biology and AI technologies into a lean R&D stack, rewiring central metabolism with novel patented pathways and enzymes to create modular gateways for a wide range of downstream products.

Traction 5/10
Paris, France · HQ
Founded 20246200+ followers
  • Biotechnology
  • Chemical Technology
  • Manufacturing / Industry 4.0
  • Artificial Intelligence
Updated 5 days ago

Funding

Funding rounds are not available yet.

Founders

Founder details are not available yet.

Product

Problem

Industrial biomanufacturing processes often underperform relative to their theoretical yields, limiting their competitiveness against traditional petrochemical routes. Additionally, many valuable chemicals cannot currently be produced from renewable feedstocks due to metabolic bottlenecks and the lack of efficient biosynthetic pathways.

Solution

Exapto provides biomanufacturing solutions designed for industrial constraints, helping companies increase the performance and competitiveness of existing bioproductions while also granting access to chemicals previously unreachable from renewable resources. The company integrates the most relevant synthetic biology and AI technologies into a lean and selective R&D stack to design optimal and unique biocomponents. By rewiring central metabolism with novel patented pathways and enzymes, Exapto creates modular gateways that provide rapid access to molecular hubs, opening a wide range of downstream products.

Target Audience

Primary customers are industrial biotechnology companies and chemical manufacturers seeking to improve the yield and cost-effectiveness of existing bioproduction processes or to produce novel chemicals from renewable feedstocks.

Features

  • Lean and selective R&D tech stack integrating synthetic biology and AI technologies
  • Optimal and unique biocomponents developed by rewiring central metabolism with novel patented pathways and enzymes
  • Modular gateways enabling rapid access to molecular hubs that support a wide product range
  • Solutions engineered for industrial constraints, emphasizing performance and competitiveness
  • Extended R&D collaborations with best-in-class academic institutions
This profile is AI-generated and may contain inaccuracies.